Wall Street Upgrades Rezolute After Strong Phase 3 Trial Results in Tumor Hyperinsulinism
Rezolute’s drug showed strong Phase 3 results, reducing IV glucose needs in rare tumor HI. Analysts raised targets and turned bullish.
NOTRELOAD AI
Strong Quarter, Heartless Cuts: GitLab Slashes Workforce and Exits 22 Countries
GitLab cuts 350 jobs, exits countries, and restructures to focus on AI-driven software and automation growth.
GameStop Delivers Best Quarter in Company History with $390M Profit and $2B Buyback
GameStop reports record Q1 2026 net income of $389.6 million and approves a $2 billion share repurchase program. Sales up 14% to $835M, driven by collectibles.
Palo Alto Networks Smashes Expectations But Investors Sell on Disclosure Worries
Palo Alto beat Q3 expectations with strong growth, raised outlook, but shares fell on reporting changes and profit concerns.
SPCE Plunges After Announcing New Share Sale to Pay Off Debt
Virgin Galactic plunged 39% in its worst day ever after announcing new shares to repay $30.5M debt.
Medline Shares Tumble After FDA Slams Repeated Bacteria Contamination at Illinois Plant
FDA warned Medline over contamination issues at Illinois plant. Stock fell. Company must fix cleaning and safety problems quickly.